Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25A | P30304 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.34 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.33 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.33 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11515636 | 1.00 | CDC25A (0.41) | CDC25ATHRBTSHRCTDSP1EPHX1 | |
| SCHEMBL10537448 | 1.00 | CDC25A (0.41) | CDC25ATHRBTSHRCTDSP1EPHX1 | |
| SCHEMBL3275678 | 1.00 | CDC25A (0.41) | CDC25ATHRBTSHRCTDSP1EPHX1 | |
| SCHEMBL4071466 | 1.00 | CDC25A (0.41) | CDC25ATHRBTSHRCTDSP1EPHX1 | |
| Fluoride Ion SCHEMBL184629 | 0.98 | CDC25A (0.41) | CDC25ATHRBTSHRCTDSP1EPHX1 | |
| Water SCHEMBL26184970 | 0.98 | CDC25A (0.41) | CDC25ATHRBTSHRCTDSP1EPHX1 | |
| SCHEMBL8965122 | 0.98 | CDC25A (0.41) | CDC25ATHRBTSHRCTDSP1EPHX1 | |
| Hydrochloric Acid SCHEMBL11781908 | 0.98 | CDC25A (0.41) | CDC25ATHRBTSHRCTDSP1EPHX1 | |
| Water SCHEMBL31291058 | 0.98 | CDC25A (0.41) | CDC25ATHRBTSHRCTDSP1EPHX1 | |
| SCHEMBL29975144 | 0.96 | CDC25A (0.40) | CDC25ATHRBTSHRCTDSP1EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117043136-A | Fluorine-based ionic liquid and method for producing same | 第一工业制药株式会社 | 2023-11-10 | — | — | CN | disclosed |
| EP-2513028-B1 | METHOD FOR PREPARING ALIZARIN DERIVATIVE COMPOUND, NOVEL ALIZARIN DERIVATIVE COMPOUND, USE OF SAID ALIZARIN COMPOUND, PHOTOELECTRIC CONVERSION FILM, PHOTOELECTRIC CONVERSION ELEMENT, AND ELECTROPHOTOGRAPHIC PHOTORECEPTOR | FUJIFILM CORP (JP) | 2018-06-20 | — | — | EP | disclosed |
| US-8741513-B2 | Method for preparing alizarin derivative compound, novel alizarin derivative compound, surface modification method, photoelectric conversion film, photoelectric conversion element, and electrophotographic photoreceptor | FUJIFILM CORPORATION (JP) | 2014-06-03 | — | — | US | disclosed |
| EP-2513028-A1 | METHOD FOR PREPARING ALIZARIN DERIVATIVE COMPOUND, NOVEL ALIZARIN DERIVATIVE COMPOUND, SURFACE MODIFICATION METHOD, PHOTOELECTRIC CONVERSION FILM, PHOTOELECTRIC CONVERSION ELEMENT, AND ELECTROPHOTOGRAPHIC PHOTORECEPTOR | FUJIFILM Corporation (JP) | 2012-10-24 | — | — | EP | disclosed |
| US-20120244462-A1 | METHOD FOR PREPARING ALIZARIN DERIVATIVE COMPOUND, NOVEL ALIZARIN DERIVATIVE COMPOUND, SURFACE MODIFICATION METHOD, PHOTOELECTRIC CONVERSION FILM, PHOTOELECTRIC CONVERSION ELEMENT, AND ELECTROPHOTOGRAPHIC PHOTORECEPTOR | FUJIFILM CORPORATION (JP) | 2012-09-27 | — | — | US | disclosed |
| WO-2011071130-A1 | METHOD FOR PREPARING ALIZARIN DERIVATIVE COMPOUND, NOVEL ALIZARIN DERIVATIVE COMPOUND, SURFACE MODIFICATION METHOD, PHOTOELECTRIC CONVERSION FILM, PHOTOELECTRIC CONVERSION ELEMENT, AND ELECTROPHOTOGRAPHIC PHOTORECEPTOR | FUJIFILM CORPORATION (JP) | 2011-06-16 | — | — | WO | disclosed |
| WO-2009040107-A2 | METHOD FOR THE PRODUCTION OF METAL-CONTAINING NANOPARTICLES | ALBERT-LUDWIGS-UNIVERSITÄT FREIBURG (DE) | 2009-04-02 | — | — | WO | disclosed |
| WO-2009024312-A2 | METHOD FOR THE PRODUCTION AND STABILIZATION OF FUNCTIONAL METAL NANOPARTICLES IN IONIC LIQUIDS | ALBERT-LUDWIGS-UNIVERSITÄT FREIBURG (DE) | 2009-02-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120244462-A1 | METHOD FOR PREPARING ALIZARIN DERIVATIVE COMPOUND, NOVEL ALIZARIN DERIVATIVE COMPOUND, SURFACE MODIFICATION METHOD, PHOTOELECTRIC CONVERSION FILM, PHOTOELECTRIC CONVERSION ELEMENT, AND ELECTROPHOTOGRAPHIC PHOTORECEPTOR | NR2E3, INA, NHERF1 | CDC25A 1480/4885THRB 4438/4885TSHR 3559/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.